Product Images Levetiracetam

Each tablet contains 250 mg of levetiracetam, an FDA-approved medication used to control seizures. The recommended storage temperature is between 20°C to 25°C, and the medication should be kept in a light-resistant, tightly closed container with a child-resistant closure. The usual dosage should be obtained from the prescribing information. The medication is manufactured in India and distributed in Levittown, PA. This prescription medication should only be dispensed by a licensed pharmacist and comes with a separate medication guide.*

Each tablet of Levetiracetam contains 500 mg of the drug. It should be stored between 20°C to 25°C and can be permitted to reach temperatures between 15°C to 30°C. It should be kept in a light-resistant container with a child-resistant closure. The recommended dosage is mentioned in the accompanying prescribing information. It is manufactured for Torrent Pharma Inc, located in Levittown, PA 19057 by Torrent Pharmaceuticals Ltd, Indrad-382 721, India. The tablets come in a bottle containing 60 units, and it is available only with a prescription.*

Levetiracetam Tablets, USP contain 750mg of levetiracetam per tablet. The recommended storage temperature is between 20°C and 25°C with allowances for excursions between 15°C and 30°C. The tablets should be dispensed in a container that is both light-resistant and child-resistant. The accompanying prescribing information should be consulted for the usual dosage. The product has been manufactured by Torrent Pharmaceuticals LTD in India with a Mfg. Lic No. G/926 and is intended for distribution by Torrent Pharma Inc. in Levittown, PA.*

Each tablet of Levetiracetam contains 1000 mg of the active ingredient. It should be stored in a tightly closed, light-resistant container at room temperature. The recommended dosage is indicated in the prescribing information. It is manufactured by Torrent Pharmaceuticals Ltd. and distributed by Torrent Pharma Inc. in Levittown, PA. This pack contains 60 tablets in a container that is light-resistant and has a child-resistant closure. A medication guide is provided separately and should be used by a pharmacist while dispensing.*

Each tablet contains 250 mg of levetiracetam, USP. The tablets come in a bottle of 60 and should be stored between 20°C to 25°C (68°F to 77°F). Rooms temperatures between 15°C to 30°C (59°F to 86°F) are permitted. Tablets must be kept in a light-resistant, tightly closed container. A licensed pharmacist must dispense the medication with the provided medication guide. The medication has been manufactured by Torrent Pharmaceuticals LTD in Bharuch-392130, India, and is being sold in Levittown, PA by Torrent Pharma Inc.*

This is a medication description for Levetiracetam Tablets, USP manufactured by Torrent Pharmaceuticals Ltd. Each tablet contains 500mg of levetiracetam, USP. They should be stored at a temperature range of 20°C to 25°C and dispensed in a tight, light-resistant container with a child-resistant closure. The usual dosage should be determined according to the accompanying prescribing information. It is manufactured for Torrent Pharma Inc. located in Levittown, PA 19057, and the NDC number is 13668-015-60.*

This is a medication label for 750 mg Levetiracetam tablets. It includes instructions for storage and dispensing, as well as manufacturing and distribution details. The recommended dosage is not included and is directed to the accompanying prescribing information. The medication is manufactured by Torrent Pharmaceuticals in India and distributed in the US by Torrent Pharma Inc. for prescription use only.*

Each tablet contains 1000 mg of levetiracetam, USP. Store between 20-25°C with excursions permitted to 15-30°C. Dispense in a tight, light-resistant container with a child-resistant closure. See the accompanying prescribing information for the usual dosage. The medication is manufactured by Torrent Pharmaceuticals in India and licensed under G/25/2010. The package contains 60 tablets labeled with NDC 13668-017-60. Pharmacists are required to dispense with the medication guide provided separately.*

This is a table that shows the percentage of patients who received a placebo compared to those who received different dosages of levetiracetam (1000mg/day and 2000mg/day). The percentages represent the proportion of patients in each group, but there is no further information available to indicate what the treatment was for or what the outcome measures were.*

This is a table containing percentages of patients for two groups of Placebo and Levetiracetam, with the number of patients in each group. There are no further details available.*

This is a statistical result indicating that the percentage of participants who received a placebo treatment in a study was 45.2%. The study also included 79 participants who were treated with levetiracetam, but no further information about the study is given.*